White Pine Capital’s Ligand Pharmaceuticals LGND Stock Holding History

White Pine Capital’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,145	Closed	-$367K	–	223
2018 Q3	$367K	Hold	2,145	–	–	0.13%	170
2018 Q2	$277K	Sell	2,145 -8,648	-80%	-$965K	0.1%	195
2018 Q1	$1.11M	Sell	10,793 -721	-6%	-$71.3K	0.41%	69
2017 Q4	$984K	Buy	11,514 +40	+0.3%	+$3.47K	0.36%	78
2017 Q3	$975	Sell	11,474 -449	-4%	-$35.6K	﹤0.01%	89
2017 Q2	$903K	Sell	11,923 -160	-1%	-$11.2K	0.36%	86
2017 Q1	$798K	Sell	12,083 -20	-0.2%	-$1.32K	0.32%	94
2016 Q4	$767K	Hold	12,103	–	–	0.33%	91
2016 Q3	$771K	Sell	12,103 -1,042	-8%	-$76.5K	0.33%	86
2016 Q2	$978K	Sell	13,145 -3,887	-23%	-$288K	0.41%	65
2016 Q1	$1.14M	Sell	17,032 -288	-2%	-$17.5K	0.49%	55
2015 Q4	$1.17M	Sell	17,320 -281	-2%	-$17.3K	0.52%	49
2015 Q3	$940K	Sell	17,601 -761	-4%	-$46.2K	0.44%	60
2015 Q2	$1.16M	Sell	18,362 -7,134	-28%	-$389K	0.5%	55
2015 Q1	$1.23M	Buy	25,496 +1,403	+6%	+$53.8K	0.5%	62
2014 Q4	$800K	Buy	24,093 +4,897	+26%	+$159K	0.27%	108
2014 Q3	$563K	Buy	19,196 +11,141	+138%	+$370K	0.19%	134
2014 Q2	$313K	Hold	8,055	–	–	0.11%	176
2014 Q1	$338K	Sell	8,055 -14,507	-64%	-$605K	0.12%	176
2013 Q4	$740K	Sell	22,562 -1,603	-7%	-$52.2K	0.26%	104
2013 Q3	$652K	Sell	24,165 -3,206	-12%	-$90.2K	0.22%	120
2013 Q2	$639K	Buy	+27,371	New	+$492K	0.22%	118

Other funds holding LGND

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

CCMLC

Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

White Pine Capital's LGND Position: Q4 2018 in Review

White Pine Capital sold out of Ligand Pharmaceuticals (LGND) in Q4 2018, closing a stake of 2,145 shares — an estimated $367K sold.

White Pine Capital first reported a position in LGND in Q2 2013 and held it in 22 quarters. The position peaked at $1.23M in Q1 2015. 362 funds tracked by Wall St. Rank hold LGND as of Q4 2018.

White Pine Capital reported no remaining Ligand Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
White Pine Capital sold 2,145 Ligand Pharmaceuticals shares in Q4 2018, an estimated $367K.
White Pine Capital first reported a position in Ligand Pharmaceuticals in Q2 2013 and held it in 22 quarters.
White Pine Capital's Ligand Pharmaceuticals position peaked at $1.23M in Q1 2015.
362 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2018.

Based on White Pine Capital's 13F filing for Q4 2018, filed 13 Feb 2019.